Hiroko Ishibashi

1.1k total citations
33 papers, 942 citations indexed

About

Hiroko Ishibashi is a scholar working on Infectious Diseases, Molecular Biology and Complementary and alternative medicine. According to data from OpenAlex, Hiroko Ishibashi has authored 33 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 8 papers in Molecular Biology and 8 papers in Complementary and alternative medicine. Recurrent topics in Hiroko Ishibashi's work include Antifungal resistance and susceptibility (16 papers), Herbal Medicine Research Studies (6 papers) and Essential Oils and Antimicrobial Activity (6 papers). Hiroko Ishibashi is often cited by papers focused on Antifungal resistance and susceptibility (16 papers), Herbal Medicine Research Studies (6 papers) and Essential Oils and Antimicrobial Activity (6 papers). Hiroko Ishibashi collaborates with scholars based in Japan, United Kingdom and New Zealand. Hiroko Ishibashi's co-authors include Shigeru Abe, Hideyo Yamaguchi, Haruyuki Oshima, Naho Maruyama, Natsuko Takakura, Yuichi Sato, Toshio Takizawa, Shigeru Abe, Katsuhisa Uchida and Hiroyuki Wakabayashi and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, International Journal of Cancer and FEMS Microbiology Letters.

In The Last Decade

Hiroko Ishibashi

33 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroko Ishibashi Japan 18 330 308 208 172 146 33 942
G Blandino Italy 19 293 0.9× 174 0.6× 407 2.0× 140 0.8× 129 0.9× 64 1.2k
Haruyuki Oshima Japan 11 246 0.7× 201 0.7× 180 0.9× 125 0.7× 91 0.6× 19 629
Gerald Pang Australia 19 86 0.3× 215 0.7× 212 1.0× 172 1.0× 172 1.2× 33 1.2k
V. Strippoli Italy 12 259 0.8× 321 1.0× 302 1.5× 176 1.0× 197 1.3× 30 929
Seyyed Amin Ayatollahi Mousavi Iran 16 110 0.3× 191 0.6× 113 0.5× 179 1.0× 184 1.3× 51 808
Shuo Jia China 19 144 0.4× 157 0.5× 340 1.6× 209 1.2× 88 0.6× 51 1.2k
Álvaro Villanueva Spain 16 329 1.0× 453 1.5× 331 1.6× 182 1.1× 440 3.0× 32 1.2k
Maria Culici Italy 15 341 1.0× 126 0.4× 160 0.8× 274 1.6× 71 0.5× 27 865
José Garrido‐Mesa Spain 23 384 1.2× 114 0.4× 829 4.0× 180 1.0× 119 0.8× 42 1.6k
Rui Tada Japan 16 126 0.4× 86 0.3× 253 1.2× 344 2.0× 93 0.6× 50 858

Countries citing papers authored by Hiroko Ishibashi

Since Specialization
Citations

This map shows the geographic impact of Hiroko Ishibashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Ishibashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Ishibashi more than expected).

Fields of papers citing papers by Hiroko Ishibashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Ishibashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Ishibashi. The network helps show where Hiroko Ishibashi may publish in the future.

Co-authorship network of co-authors of Hiroko Ishibashi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Ishibashi. A scholar is included among the top collaborators of Hiroko Ishibashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Ishibashi. Hiroko Ishibashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hisajima, Tatsuya, et al.. (2012). Pathological analysis of the Candida albicans-infected tongue tissues of a murine oral candidiasis model in the early infection stage. Archives of Oral Biology. 58(4). 444–450. 15 indexed citations
2.
Hayama, Kazumi, et al.. (2010). Therapeutic Effect of Oligonol, a Low-molecular Polyphenol Formulation Derived from Lychee Fruits on Murine Oral Candidiasis. Nippon Ishinkin Gakkai Zasshi. 51(3). 137–142. 8 indexed citations
3.
Takizawa, Toshio, et al.. (2010). Therapeutic Effects on Murine Oral Candidiasis by Oral Administration of Cassia ( Cinnamomum cassia ) Preparation. Nippon Ishinkin Gakkai Zasshi. 51(1). 13–21. 24 indexed citations
4.
Hisajima, Tatsuya, Naho Maruyama, Yuko Tanabe, et al.. (2008). Protective effects of farnesol against oral candidiasis in mice. Microbiology and Immunology. 52(7). 327–333. 49 indexed citations
5.
Nonaka, Yuji, Hiroko Ishibashi, Masaaki Nakai, et al.. (2008). Effects of the Antlered Form ofGanoderma lucidumon Tumor Growth and Metastasis in Cyclophosphamide-Treated Mice. Bioscience Biotechnology and Biochemistry. 72(6). 1399–1408. 24 indexed citations
6.
Hu, Weimin, Hiroko Ishibashi, Naho Maruyama, et al.. (2007). A novel murine model of pharyngeal candidiasis with local symptoms characteristic of pharyngeal thrush produced by using an inhaled corticosteroid. Medical Mycology. 45(2). 143–148. 5 indexed citations
7.
Inoue, Kouichi, Yasumasa Suzuki, Shunji Nomura, et al.. (2007). . Folia Pharmacologica Japonica. 130(1). 69–76. 1 indexed citations
8.
Tansho, Shigeru, et al.. (2007). Efficacy of intravenous itraconazole against invasive pulmonary aspergillosis in neutropenic mice. Journal of Infection and Chemotherapy. 12(6). 355–362. 10 indexed citations
9.
Maruyama, Naho, Hiroko Ishibashi, Weimin Hu, et al.. (2006). Suppression of Carrageenan‐ and Collagen II‐Induced Inflammation in Mice by Geranium Oil. Mediators of Inflammation. 2006(1). 62537–62537. 24 indexed citations
10.
Nonaka, Yuji, Hiroshi Shibata, Masaaki Nakai, et al.. (2006). Anti-Tumor Activities of the Antlered Form ofGanoderma lucidumin Allogeneic and Syngeneic Tumor-Bearing Mice. Bioscience Biotechnology and Biochemistry. 70(9). 2028–2034. 24 indexed citations
11.
Maruyama, Naho, Hiroko Ishibashi, Shigeharu Inouye, et al.. (2005). Suppression of neutrophil accumulation in mice by cutaneous application of geranium essential oil.. Journal of Inflammation. 2(1). 1–1. 65 indexed citations
12.
Ishibashi, Hiroko, et al.. (2005). Protection of Oral or Intestinal Candidiasis in Mice by Oral or Intragastric Administration of Herbal Food, Clove (Syzygium aromaticum). Nippon Ishinkin Gakkai Zasshi. 46(1). 27–33. 17 indexed citations
13.
Tansho, Shigeru, Shigeru Abe, Hiroko Ishibashi, et al.. (2004). Production of anti‐Candida antibodies in mice with gut colonization of Candida albicans. Mediators of Inflammation. 13(3). 189–193. 5 indexed citations
14.
Abe, Shigeru, Weimin Hu, Hiroko Ishibashi, Hideyo Yamaguchi, & Keiji Hasumi. (2004). Augmented inhibition of Candida albicans growth by murine neutrophils in the presence of a tryptophan metabolite, picolinic acid. Journal of Infection and Chemotherapy. 10(3). 181–184. 16 indexed citations
15.
Abe, Shigeru, Naho Maruyama, Kazumi Hayama, et al.. (2003). Suppression of tumor necrosis factor‐alpha‐induced neutrophil adherence responses by essential oils. Mediators of Inflammation. 12(6). 323–328. 85 indexed citations
16.
Ishibashi, Hiroko, et al.. (2003). Prophylactic Efficacy of A Basidiomycetes Preparation AHCC against Lethal Candida albicans Infection in Experimental Granulocytopenic Mice. Nippon Ishinkin Gakkai Zasshi. 44(2). 127–131. 5 indexed citations
17.
Abe, Shigeru, Yuichi Sato, Hiroko Ishibashi, et al.. (2003). Anti-Candida albicans Activity of Essential Oils Including Lemongrass (Cymbopogon citratus) Oil and its Component, Citral. Nippon Ishinkin Gakkai Zasshi. 44(4). 285–291. 79 indexed citations
18.
Abe, Shigeru, Hiroko Ishibashi, Shigeru Tansho, et al.. (2000). Protective Effect of Oral Administration of Several Traditional Kampo-Medicines on Lethal Candida Infection in Immunosuppressed Mice.. Nippon Ishinkin Gakkai Zasshi. 41(2). 115–119. 8 indexed citations
19.
Abe, Shigeru, et al.. (1998). Protective Effect of Oral Administration of: A Traditional Medicine, Juzen-Taiho-To, and Its Components on LethalCandida AlbicansInfection in Immunosuppressed Mice. Immunopharmacology and Immunotoxicology. 20(3). 421–431. 24 indexed citations
20.
Tanaka, Hajime, et al.. (1995). Increased experimental pulmonary metastasis in pregnant mice. International Journal of Cancer. 62(3). 314–318. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Blandino Breakdown of academic impact, for papers by Haruyuki Oshima Breakdown of academic impact, for papers by Gerald Pang Breakdown of academic impact, for papers by V. Strippoli Breakdown of academic impact, for papers by Seyyed Amin Ayatollahi Mousavi Breakdown of academic impact, for papers by Shuo Jia Breakdown of academic impact, for papers by Álvaro Villanueva Breakdown of academic impact, for papers by Maria Culici Breakdown of academic impact, for papers by José Garrido‐Mesa Breakdown of academic impact, for papers by Rui Tada
Rankless by CCL
2026